Trial Scorecards

August 2009
Cardiology Today;Aug2009, Vol. 12 Issue 8, p10
The article summarizes the results of different clinical trials in cardiology including the Beta-Blocker Evaluation of Survival Trial (BEST), Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome (JAPAN-ACS), and Myocardial Ischemia Reducation with Aggressive Cholesterol Lowering (MIRACL).


Related Articles

  • Which Parameter Should Be Chosen as Primary Endpoint for Randomized Drug-Eluting Stent Studies? SILBER, SIGMUND // Journal of Interventional Cardiology;Dec2004, Vol. 17 Issue 6, p375 

    In Europe, 1,108 percutaneous coronary interventions (PCIs) per one Mio inhabitants are currently annually performed, most of them with stent implantation. Drug-eluting stents have been the focus of attention of interventional coronary therapy since the RAVEL study was first presented in...

  • Use and Misuse of Multivariable Approaches in Interventional Cardiology Studies on Drug-Eluting Stents: A Systematic Review. D'ASCENZO, FABRIZIO; CAVALLERO, ERIKA; BIONDI-ZOCCAI, GIUSEPPE; MORETTI, CLAUDIO; OMEDÈ, PIERLUIGI; BOLLATI, MARIO; CASTAGNO, DAVIDE; MODENA, MARIA GRAZIA; GAITA, FIORENZO; SHEIBAN, IMAD // Journal of Interventional Cardiology;Dec2012, Vol. 25 Issue 6, p611 

    Aims: Randomized clinical trials (RCTs) are the most reliable evidence, even if they require important resource and logistic efforts. Large, cost-free and real-world datasets may be easily accessed yielding to observational studies, but such analyses often lead to problematic results in the...

  • Guidelines to Practice Gap in the Use of Glycoprotein IIb/IIIa Inhibitors: From ISAR-REACT to Overreact? Viswanathan, G.; Javed, S.; Mayurathan, G.; Sallehuddin, S.; Jamieson, S.; Zaman, A. G. // Journal of Interventional Cardiology;Apr2009, Vol. 22 Issue 2, p163 

    Adjunctive use of glycoprotein IIb/IIIa inhibitors (GPI) is associated with favorable outcomes following percutaneous coronary intervention (PCI). Guidelines for use of GPI have been published by various national societies including National Institute of Clinical Excellence (NICE), United...

  • Dear Colleagues. Giugliano, Gregory R.; Giugliano, Robert P. // MD Conference Express;Dec2011, p2 

    The article highlights the topics discussed from the Transcatheter Cardiovascular Therapeutics (TCT) 2011 meeting held in San Francisco, California on November 7-11, 2011. It showcased the advances in therapies and clinical research relevant to cardiologists who specializes in the structure and...

  • Event detection using population-based health care databases in randomized clinical trials: a novel research tool in interventional cardiology. Thuesen, Leif; Jensen, Lisette Okkels; Tilsted, Hans Henrik; Mæng, Michael; Terkelsen, Christian; Thayssen, Per; Ravkilde, Jan; Christiansen, Evald Høj; Bøtker, Hans Erik; Madsen, Morten; Lassen, Jens F. // Clinical Epidemiology;2013, Vol. 5, p357 

    Aim: To describe a new research tool, designed to reflect routine clinical practice and relying on population-based health care databases to detect clinical events in randomized clinical trials. Background: Randomized clinical trials often focus on short-term efficacy and safety in a controlled...

  • More Trouble Over EU Clinical Trials Rules. O'Donnell, Peter // Applied Clinical Trials;Jan2003, Vol. 12 Issue 1, p21 

    Focuses on the views of health practitioners on the problems associated with the implementation of the European Union directive on clinical trials. Effects of disparate legal regulations on the success of international clinical trials; Details of the protocol amendment procedures and...

  • Study Completion Times.  // Applied Clinical Trials;May2011, Vol. 20 Issue 5, p19 

    The article offers analysis on the study completion times on applied clinical trials of contract research organization or sponsor company of the study in the U.S.

  • Clinical trials: Free help for the asking!  // Hispanic Times Magazine;May/Jun1994, Vol. 15 Issue 3, p34 

    Discusses clinical trials--closely supervised investigations to evaluate new medical treatments for various maladies. How people who have received no relief for their ailment from conventional medicines may want to try a clinical trial; What they usually entail; Requirements involved; How to...

  • How to evaluate the validity and usefulness of published randomized clinical trials. Basskin, Lorne // Formulary;Mar1997, Vol. 32 Issue 3, p279 

    Presents evaluation on the validity and usefulness of published randomized clinical trials. Assessment of validity through cause-and-effect relationship; Four questions in studying usefulness. INSETS: Reasons to review randomized clinical trials (RCTs).;Shortfalls of some information...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics